Nectar Life Sciences recently made two personnel moves to bolster its C-suite.

The New York-based health tech company named Shyam Joshi, MD as its first chief scientific officer and tapped Tania Elliott, MD to serve as chief medical officer. 

Joshi has been part of Nectar’s operations for the past two years, the company stated, and will support its clinical research and validation efforts. In this role, Joshi will be responsible for setting Nectar’s research priorities, developing trials to prove the validity and safety of products and overseeing all scientific operations. 

In addition to his position at Nectar, Joshi serves as section chief of allergy and immunology as well as medical director of the allergy and immunology clinic at Oregon Health and Science University. 

Meanwhile, Elliott will be responsible for driving the organization’s clinical strategy and quality while also serving as the “public face of Nectar.” Elliott is tasked with educating patients about allergies and potential treatment options.

Prior to joining Nectar, Elliott served as chief medical officer of virtual care at Ascension, one of the country’s largest private healthcare systems. In that capacity, she ran Ascension’s ambulatory care and inpatient telehealth services as well as its remote patient monitoring programs for asthma and COVID-19. 

Earlier in her career, Elliott was the medical director of clinical solutions at Aetna, a CVS Health Company and held executive positions at EHE Health as well as Doctor on Demand (now Included Health.)

In the academic realm, Elliott is a faculty mentor for Stanford University’s Master of Science in Clinical Informatics Management program, a clinical instructor at NYU Langone Health as well as a senior fellow for the Potomac Institute for Policy Studies. 

Elliott is on the board of directors for the American Telemedicine Association and also serves as the chair of the American College of Allergy, Asthma, and Immunology’s telehealth and technology taskforce.

In addition to her lengthy industry credentials, Elliott was included on MM+M’s 2019 Healthcare Transformer list and spoke at the 2022 MM+M Transform conference in her capacity as an Ascension executive. 

The two leadership appointments are a sizable development for a burgeoning health tech company.

Since its launch in early 2022, Nectar raised more than $24 million to support the growth of its vertically-integrated allergy care platform.